Royal DSM N.V., the global Life Sciences and Materials Sciences company headquartered in the Netherlands, today received the 2009 Outstanding Corporate Innovator Award from the Product Development and Management Association (PDMA) in recognition of its strategic commitment to Open Innovation. Considered to be one of the world’s most important innovation awards, the Outstanding Corporate Innovator Award recognizes organizations that demonstrate exceptional skill in continuously creating and capturing value through new product and service development.

Q3 operating profit from continuing operations EUR 139 million, more than double Q2 2009 (EUR 58 million). Strong Life Sciences performance due to robust Nutrition business. Materials Sciences continued strong recovery. Cost savings and efficiency improvements on track to achieve EUR 150 – 200 million on yearly basis by 2010. Cash flow from operating activities again very strong (Q3 EUR 517 million). Outlook for the rest of the year remains uncertain; Q4 operating profit currently expected to be lower than Q3, but above Q4 last year.

Royal DSM N.V., the global Life Sciences and Materials Sciences company headquartered in the Netherlands, today announces that the contracts to establish nutrition and anti-infectives joint ventures in China with North China Pharmaceutical Group Corporation Ltd. (NCPC) are suspended. DSM will continue its search for partners in China as the company prepares for further growth in the country, which in 2008 represented 8% of DSM’s net sales.

Royal DSM N.V., the global Life Sciences and Materials Sciences company headquartered in the Netherlands, announces today that Jan Zuidam, Deputy Chairman of the Managing Board of Directors of DSM, will retire on 1 January 2010, after 36 years of service with DSM, of which he served 12 years as member of DSM’s Managing Board.

Royal DSM N.V., the global Life Sciences and Materials Sciences company headquartered in the Netherlands, today announces that it has been awarded the international AVK Innovation Award in the Environment category for a new, lightweight version of air-cargo containers. The containers help airlines to cut carbon emissions by 28,000 tons a year, the equivalent of taking more than 8,500 cars off the road.

Royal DSM N.V., the global Life Sciences and Materials Sciences company headquartered in the Netherlands, announces today that ®claryl picture glass was awarded the 2009 ICIS Innovation Award for Best Business Innovation.

Royal DSM N.V., the global Life Sciences and Materials Sciences company headquartered in the Netherlands, and Maire Tecnimont S.p.A., a leading international engineering and construction group headquartered in Italy, announce that they have finalized today the sale of DSM’s urea-licensing subsidiary Stamicarbon B.V. to Maire Tecnimont for a total consideration of EUR 38 million on a cash and debt-free basis.

Royal DSM N.V., the global Life Sciences and Materials Sciences company headquartered in the Netherlands, announces today that the DSM Nutrition Award 2009 for research on Human Nutrition has been granted jointly to Professor Michael F. Holick of Boston University, USA, and Professor Heike A. Bischoff-Ferrari of the University of Zurich, Switzerland, in recognition of their seminal contributions to research on vitamin D and its role in human nutrition and health.

Royal DSM N.V., the global Life Sciences and Materials Sciences company headquartered in the Netherlands, announces today that it has finalized the sale of DSM Energie Holding B.V. (DSM Energy) to TAQA Abu Dhabi National Energy Company PJSC on 30 September 2009.

Royal DSM N.V., the global Life Sciences and Materials Sciences company headquartered in the Netherlands, announces today that its KhepriCoat™ anti-reflective coating system has contributed to achieving the highest energy conversion ever of a full-size solar module.

Royal DSM N.V., the global Life Sciences and Materials Sciences company headquartered in the Netherlands, today will update investors and analysts at its annual Analysts Conference in Amsterdam (NL) on the progress made with its Vision 2010 strategy. DSM is also providing an update on recent trading conditions.

Royal DSM N.V., the global Life Sciences and Materials Sciences company headquartered in the Netherlands, has regained its number one position in the chemical industry sector in the Dow Jones Sustainability World Index*, published today. From 2004 to 2006 DSM was named the worldwide sustainability No. 1 in this sector. In 2007 and 2008 it ranked amongst the top leaders in the sector.

Q2 operating profit from continuing operations clearly higher than Q1 2009. Q2 total operating profit of EUR 79 million, substantially down from last year’s record. Nutrition business remains robust. Materials Sciences recovers from first quarter losses. Cash flow from operating activities once again very strong (EUR 267 million); 44% higher than Q2 2008. Interim dividend unchanged at EUR 0.40 per ordinary share. The outlook remains uncertain, although the initial impact of inventory write-downs and customer de-stocking now looks to be largely over.

Royal DSM N.V. today provides the investment community with comparative quarterly figures for 2008 and Q1 2009.

Royal DSM N.V., the global Life Sciences and Materials Sciences company headquartered in the Netherlands, announces today that it has reached an agreement with TAQA Abu Dhabi National Energy Company PJSC for the sale of DSM Energie Holding B.V. (DSM Energy) for an enterprise value of EUR 285 million. The intended sale is expected to close in Q3 2009, subject to regulatory approvals and notifications.

Royal DSM N.V., the global Life Sciences and Materials Sciences company headquartered in the Netherlands, and Maire Tecnimont S.p.A., a leading international engineering and construction group headquartered in Italy, announce today that they have reached an agreement for the sale of DSM’s urea-licensing subsidiary Stamicarbon B.V. to Maire Tecnimont for a total consideration of EUR 38 million on a cash and debt-free basis. The intended sale is expected to close by Q4 2009, subject to regulatory and other customary approvals and notifications.

Royal DSM N.V., the global Life Sciences and Materials Sciences company headquartered in the Netherlands, today announced that it has officially endorsed the ‘Roadmap to End Global Hunger’, a comprehensive strategy announced by a broad based coalition of leading humanitarian organizations aimed at addressing global hunger through short, mid range and long term initiatives focused on achieving the Millennium Development Goals of halving global hunger by 2015.

Royal DSM N.V., the global Life Sciences and Materials Sciences company headquartered in the Netherlands, today announces the following management appointment: Ben van Dijk (1951) at present Executive Vice President Corporate Human Resources, will be appointed Director Strategic Projects with effect from 1 September 2009.

Royal DSM N.V., the global Life Sciences and Materials Sciences company headquartered in the Netherlands, today announces the following management appointment: Jos Goessens (1951) at present Executive Vice President Strategic Projects, will be appointed Executive Vice President DSM Expert Center (DEC) with effect from 1 July 2009.

Swiss researcher Alexandra Teleki has won the first prize in the DSM Science & Technology Awards (South) 2009.

Belgian researcher Peter Dedecker has won the first prize in the DSM Science & Technology Awards (North) 2009.

Royal DSM N.V., the global Life Sciences and Materials Sciences company headquartered in the Netherlands, today announces an agreement to acquire Biopract GmbH, based in Berlin (Germany). The acquisition of privately held Biopract will serve as an entry point for DSM into the promising biogas market, which is showing 15-20% growth per year.

Royal DSM N.V., the global Life Sciences and Materials Sciences company headquartered in the Netherlands, and Mitsubishi Chemical Corporation (MCC) today announce that they have signed a memorandum of understanding for DSM to acquire MCC’s Novamid® polyamide business in exchange for DSM’s Xantar® polycarbonate business.

Royal DSM N.V., the global Life Sciences and Materials Sciences company headquartered in the Netherlands, today announces that it will quadruple production capacity for Stanyl® ForTii™ in order to meet market demand for this new polymer, which is used in electronics and other applications.

Q1 operating profit down to EUR 57 million. Continuing strong performance from Life Sciences businesses. Most Materials Sciences businesses severely impacted by downturn. Continued strong cash performance, EUR 166 million cash from operating activities. No quantitative outlook provided for 2009 in view of uncertain economic conditions.

Royal DSM N.V., the global Life Sciences and Materials Sciences company headquartered in the Netherlands, today provides the investment community with comparative quarterly figures for 2008.

Royal DSM N.V., the global Life Sciences and Materials Sciences company headquartered in the Netherlands, today announces that it has entered into a multi-million dollar contract with Shire US Manufacturing Inc., a subsidiary of Shire plc., for the manufacture and supply of specialty pharmaceutical products to Shire.

The DSM Annual General Meeting of Shareholders on 25 March 2009 passed a resolution to declare a dividend for 2008 of EUR 1.20 per ordinary share of EUR 1.50 par value. An interim dividend of EUR 0.40 per ordinary share having been paid on 22 August 2008, the final dividend for 2008 will amount to EUR 0.80 per ordinary share.

Royal DSM N.V. today held its Annual General Meeting of Shareholders.

Royal DSM N.V., the global Life Sciences and Materials Sciences company headquartered in the Netherlands, North China Pharmaceutical Group Corporation Ltd. (NCPC GroupCo) of Shijiazhuang, Hebei Province, People’s Republic of China, NCPC ListCo, the listed affiliate of NCPC and the State-owned Assets Supervision and Administration Commission of the State Council (SASAC) of Hebei Province today announce that they have signed the contracts regarding investment by DSM in NCPC GroupCo and the establishment of three joint ventures in the areas of nutritional products and anti-infectives.

Royal DSM N.V., the global Life Sciences and Materials Sciences company headquartered in the Netherlands, today announces the following management changes: Mr. Ben van Dijk, currently Executive Vice President Corporate Human Resources is ready for a new challenge after leading the Human Resource function of DSM for 10 years. Mr. Paul Jarrell will be appointed as Executive Vice President Corporate Human Resources as per 1 September.

Royal DSM N.V., the global Life Sciences and Materials Sciences company headquartered in the Netherlands, presents its seventh annual sustainability report, the Triple P report (People, Planet, Profit) 2008. This year’s report has achieved an A + rating according to the guidelines of the Global Reporting Initiative (GRI). This is the highest score companies worldwide can achieve for the transparency of their sustainability reporting efforts.

Royal DSM N.V., the global Life Sciences and Materials Sciences company headquartered in the Netherlands, today announces that DSM Biomedical obtained an exclusive world-wide license for a unique drug & biologics delivery system developed by MediVas LLC. Integrated into DSM’s Trancerta® Drug Delivery platform, this will open up a broad range of opportunities for next generation drug delivery. DSM’s activities in this field are an illustration of the way DSM is leveraging its competences in Materials Sciences into Life Sciences applications.

Royal DSM N.V., the global Life Sciences and Materials Sciences company headquartered in the Netherlands, announces today that it has opened a new manufacturing facility for producing engineering plastics compounds in India. With this new greenfield facility, DSM underlines its long term commitment to one of the world’s largest and fastest growing emerging economies.

Royal DSM N.V., the global Life Sciences and Materials Sciences company headquartered in The Netherlands, has successfully issued a EUR 500 million 5.75% bond due 2014.

Royal DSM N.V., the global Life Sciences and Materials Sciences company headquartered in the Netherlands, announces today that its Managing Board and Supervisory Board have decided to withdraw a proposal to the Annual General Meeting of Shareholders (AGM) to change the Total Shareholder Return vesting scheme for stock options and performance shares (stock incentives).

Royal DSM NV, the world’s leading Life and Materials Sciences company, announced today a scientific breakthrough in tackling iron deficiency and malaria in partnership with the World Food Programme. It has found a new way to resolve a longstanding nutrition problem – using its enzyme expertise to provide iron to those suffering from iron deficiency, without increasing the risk of malaria.

Royal DSM N.V., the global Life Sciences and Materials Sciences company headquartered in the Netherlands, and the French starch and starch-derivatives company ROQUETTE confirmed during the international Life Sciences Forum, BioVision, that its bio-based succinic acid demonstration plant in Lestrem (France) will be operational by the end of 2009. The pilot scale production has proven that this biological route for producing succinic acid can be commercially viable. The first tests for customers are already underway with this ‘green’ succinic acid.

Royal DSM N.V., the global Life Sciences and Materials Sciences company headquartered in the Netherlands, announces that today a new factory for waterborne acrylic resins has been opened in Waalwijk (Netherlands). Total investment costs amounted to EUR 30 million.

Royal DSM N.V., the global Life Sciences and Materials Sciences company headquartered in the Netherlands, today announces the following management appointment: Ms Femke Weijtens (41) at present Director External Relations at Schretlen en Co N.V. (the Netherlands), will join DSM on 1 April 2009 and prepare for her new position as Corporate Secretary. She will succeed Paul Fuchs, who retires with effect from 1 September 2009.

Royal DSM N.V., the global Life Sciences and Materials Sciences company headquartered in the Netherlands, announces today that credit rating agencies Standard & Poor’s and Moody’s have confirmed their credit ratings for the company.

Full year operating profit up 10% to EUR 903 million; Q4 down 35% to EUR 123 million. Continuing strong performance from Life Sciences businesses and DSM Dyneema in Q4. Most Materials Sciences businesses severely impacted by downturn since beginning of Q4. Focus on cash over profitability generates strong cash flow in Q4; cost saving program of EUR 100 million under way. Solid long-term financial position; dividend maintained at EUR 1.20 per share. No quantitative outlook provided for 2009 in view of the uncertain economic conditions.

Royal DSM N.V., the global Life Sciences and Materials Sciences company headquartered in the Netherlands, today announces that its Triple P report 2008 achieves an A + according to the guidelines of the Global Reporting Initiative (GRI). The A + rating is the highest score companies worldwide can achieve for the transparency of their sustainability reporting efforts.

Royal DSM N.V., the global Life Sciences and Materials Sciences company headquartered in the Netherlands, announces that today exactly twenty years ago the company was first listed on Euronext Amsterdam. To celebrate this anniversary Feike Sijbesma, Chairman of the DSM Managing Board, earlier today rang the opening bell on Euronext Amsterdam.

Royal DSM N.V., the global Life Sciences and Materials Sciences company headquartered in the Netherlands, today announces that the previously announced sale of DSM Special Products BV to Arsenal Capital Partners (United States) will not be completed.

Royal DSM N.V., the global Life Sciences and Materials Sciences company headquartered in the Netherlands, today announces the following management appointment: Luca Rosetto (1963) at present Business Unit Director Europe / Americas within the Business Group DSM Anti-Infectives, will be appointed Corporate Vice President Safety, Health, Environment and Manufacturing (CSHE&M) with effect from 1 March 2009.

Royal DSM N.V., the global Life Sciences and Materials Sciences company headquartered in the Netherlands, today announces the following management appointment: Hans van Suijdam (1950) at present Director Strategic Projects in China, will be appointed Director Corporate Operational Audit (COA) and Compliance Officer as per 1 April 2009.

Royal DSM N.V., the global Life Sciences and Materials Sciences company headquartered in the Netherlands, today announces the opening of its DSM China Campus in the Zhangjiang Hi-Tech Park in Pudong New Area, Shanghai. The Campus will advance local research and development competence and as it is one of the first LEED Gold-certified buildings in China, it will become a symbol of DSM’s sustainable development in China.

Royal DSM N.V., the global Life Sciences and Materials Sciences company headquartered in the Netherlands, today announces the following management appointments: Gerard de Reuver (1956) at present Business Group Director DSM Anti-Infectives (DAI), will be appointed Director Strategic Projects as per 1 March 2009. Stefan Doboczky (1967) at present Business Unit Director DAI China, will succeed Gerard de Reuver as Business Group Director DAI as of 1 March 2009.